AN INNOVATIVE TECHNICAL PLATFORM FOR THE DEVELOPMENT AND TRADE OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY DIAGNOSTIC TESTING (Q2043834): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item)
(‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair)
description / endescription / en
Project in Italy financed by DG Regio
Project Q2043834 in Italy
description / itdescription / it
Progetto in Italia finanziato da DG Regio
Progetto Q2043834 in Italia

Revision as of 08:41, 2 November 2020

Project Q2043834 in Italy
Language Label Description Also known as
English
AN INNOVATIVE TECHNICAL PLATFORM FOR THE DEVELOPMENT AND TRADE OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY DIAGNOSTIC TESTING
Project Q2043834 in Italy

    Statements

    0 references
    15,000.0 Euro
    0 references
    30,000.0 Euro
    0 references
    50.0 percent
    0 references
    25 October 2017
    0 references
    15 October 2018
    0 references
    30 December 2019
    0 references
    ARDIS S.R.L.
    0 references
    0 references

    45°11'9.60"N, 9°9'16.70"E
    0 references
    AN INNOVATIVE TECHNOLOGY PLATFORM FOR THE DEVELOPMENT AND COMMERCIALISATION OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY PRE-TREATMENT DIAGNOSTIC TESTING (Italian)
    0 references
    AN INNOVATIVE TECHNICAL PLATFORM FOR THE DEVELOPMENT AND TRADE OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY DIAGNOSTIC TESTING (English)
    0 references

    Identifiers

    E17F17000030002
    0 references